Clinical Trials Browser

INDUSTRY × Erlotinib Hydrochloride × CNS × Clear all

NCT03653546 2025-09-10

BM

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

NCT00337883 2014-03-04

A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)

Phase 2 Completed

Glioblastoma, Glioma